je.st
news
Home
› ForteBio Launches Dip And Read Anti-Human Fab-CH1 Biosensor To Accelerate Human Biotherapeutic Drug Development
ForteBio Launches Dip And Read Anti-Human Fab-CH1 Biosensor To Accelerate Human Biotherapeutic Drug Development
2013-01-09 18:00:00| drugdiscoveryonline News Articles
ForteBio, a division of Pall Life Sciences and a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, recently announced the launch of its Dip and Read Anti-Human Fab-CH1 biosensor
Tags: read
development
human
drug
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||